These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 18769210)

  • 41. Endocrine disruptors and reproductive development: a weight-of-evidence overview.
    Cooper RL; Kavlock RJ
    J Endocrinol; 1997 Feb; 152(2):159-66. PubMed ID: 9071972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endocrine disruptors: from endocrine to metabolic disruption.
    Casals-Casas C; Desvergne B
    Annu Rev Physiol; 2011; 73():135-62. PubMed ID: 21054169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review.
    Samtani R; Sharma N; Garg D
    Reprod Sci; 2018 Jan; 25(1):7-18. PubMed ID: 28602118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologic and Environmental Endocrine Disruptors in the Pathogenesis of Hypospadias: a Review.
    Raghavan R; Romano ME; Karagas MR; Penna FJ
    Curr Environ Health Rep; 2018 Dec; 5(4):499-511. PubMed ID: 30578470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Our stolen figures: the interface of sexual differentiation, endocrine disruptors, maternal programming, and energy balance.
    Schneider JE; Brozek JM; Keen-Rhinehart E
    Horm Behav; 2014 Jun; 66(1):104-19. PubMed ID: 24681201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences.
    Gilbert ME; Rovet J; Chen Z; Koibuchi N
    Neurotoxicology; 2012 Aug; 33(4):842-52. PubMed ID: 22138353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of endocrine disruptors on the reproductive system - current knowledge.
    Czarnywojtek A; Jaz K; Ochmańska A; Zgorzalewicz-Stachowiak M; Czarnocka B; Sawicka-Gutaj N; Ziółkowska P; Krela-Kaźmierczak I; Gut P; Florek E; Ruchała M
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(15):4930-4940. PubMed ID: 34355365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocrine disrupters as obesogens.
    Grün F; Blumberg B
    Mol Cell Endocrinol; 2009 May; 304(1-2):19-29. PubMed ID: 19433244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocrine disruptors and the obesity epidemic.
    Heindel JJ
    Toxicol Sci; 2003 Dec; 76(2):247-9. PubMed ID: 14677558
    [No Abstract]   [Full Text] [Related]  

  • 50. Obesogenic endocrine disruptors and obesity: myths and truths.
    Muscogiuri G; Barrea L; Laudisio D; Savastano S; Colao A
    Arch Toxicol; 2017 Nov; 91(11):3469-3475. PubMed ID: 28975368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Environmental endocrine disruptors and obesity.
    Karoutsou E; Polymeris A
    Endocr Regul; 2012 Jan; 46(1):37-46. PubMed ID: 22329821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transgenerational effects of obesogens.
    Lee MK; Blumberg B
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125 Suppl 3(Suppl 3):44-57. PubMed ID: 30801972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Environmental endocrine disruption of energy metabolism and cardiovascular risk.
    Kirkley AG; Sargis RM
    Curr Diab Rep; 2014 Jun; 14(6):494. PubMed ID: 24756343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endocrine Disruptors and the Induction of Insulin Resistance.
    Vanni R; Bussuan RM; Rombaldi RL; Arbex AK
    Curr Diabetes Rev; 2021; 17(7):e102220187107. PubMed ID: 33092513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocrine disruptive compounds and cardio-metabolic risk factors in children.
    Khalil N; Chen A; Lee M
    Curr Opin Pharmacol; 2014 Dec; 19():120-4. PubMed ID: 25306432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Endocrine disruptors and metabolic diseases: a major public health challenge].
    Nalbone G; Cicolella A; Laot-Cabon S
    Sante Publique; 2013; 25(1):45-9. PubMed ID: 23705334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exposure to environmental endocrine disruptors and child development.
    Meeker JD
    Arch Pediatr Adolesc Med; 2012 Jun; 166(6):E1-7. PubMed ID: 22664748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obesity II: Establishing causal links between chemical exposures and obesity.
    Heindel JJ; Howard S; Agay-Shay K; Arrebola JP; Audouze K; Babin PJ; Barouki R; Bansal A; Blanc E; Cave MC; Chatterjee S; Chevalier N; Choudhury M; Collier D; Connolly L; Coumoul X; Garruti G; Gilbertson M; Hoepner LA; Holloway AC; Howell G; Kassotis CD; Kay MK; Kim MJ; Lagadic-Gossmann D; Langouet S; Legrand A; Li Z; Le Mentec H; Lind L; Monica Lind P; Lustig RH; Martin-Chouly C; Munic Kos V; Podechard N; Roepke TA; Sargis RM; Starling A; Tomlinson CR; Touma C; Vondracek J; Vom Saal F; Blumberg B
    Biochem Pharmacol; 2022 May; 199():115015. PubMed ID: 35395240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies Workshop.
    Heindel JJ; Alvarez JA; Atlas E; Cave MC; Chatzi VL; Collier D; Corkey B; Fischer D; Goran MI; Howard S; Kahan S; Kayhoe M; Koliwad S; Kotz CM; La Merrill M; Lobstein T; Lumeng C; Ludwig DS; Lustig RH; Myers P; Nadal A; Trasande L; Redman LM; Rodeheffer MS; Sargis RM; Stephens JM; Ziegler TR; Blumberg B
    Am J Clin Nutr; 2023 Jul; 118(1):329-337. PubMed ID: 37230178
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exposure to Endocrine-Disrupting Chemicals During Pregnancy Is Associated with Weight Change Through 1 Year Postpartum Among Women in the Early-Life Exposure in Mexico to Environmental Toxicants Project.
    Perng W; Kasper NM; Watkins DJ; Sanchez BN; Meeker JD; Cantoral A; Solano-González M; Tellez-Rojo MM; Peterson K
    J Womens Health (Larchmt); 2020 Nov; 29(11):1419-1426. PubMed ID: 32233978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.